A number of our lawyers hold scientific degrees and have in-house
experience at life sciences companies and service providers. That means we
have the fundamental knowledge to understand our clients' science,
operations and business strategies. We strive to be part of our clients'
team throughout the life cycle of their products, from development and
navigating regulatory issues, to raising capital and marketing, and when
necessary, advancing their interests in court.
Our multidisciplinary team offers services tailored to the needs of
biotech, medical device, diagnostics and pharmaceutical companies at all
stages of growth. We successfully serve clients in the following legal
Corporate & Finance Transactions
– We advise on complex mergers and acquisitions, financings, public and
private securities offerings and other capital-raising transactions,
licensing agreements, joint ventures and strategic partnering arrangements.
Our work with private equity investors, commercial banks and other
financial institutions showcases our skills handling issues in the life
sciences investment space. The volume of deals we do each year has led Thomson Reuters and Bloomberg to consistently rank
McGuireWoods among the top 10 M&A and corporate finance firms in the
Regulatory & Compliance
– We counsel on compliance matters that arise during daily operations,
strategic planning, and sales and marketing planning, including federal and
state anti-kickback laws, FDA regulations, digital health and cyber
security, and other regulations governing the manufacture, sale,
distribution and marketing of pharmaceuticals, medical devices and other
products. The team analyzes compliance strategies, prepares and files FDA
submissions, provides benchmarking audits and analysis of regulatory and
liability postures, establishes and monitors internal compliance programs,
and takes clients through implementation.
– We understand the vital role of intellectual property in the industry,
and are well versed in the regulatory framework that spurs innovation in
the biotech, medical device, diagnostics and pharmaceutical space. We
advise on patent prosecution and defense, patent portfolio strategy
development, monitoring of competitive technologies, guidance on trademark,
copyright, trade secret protection and enforcement issues, licensing,
pursuit of counterfeiters and gray-market diverters, and transactional due
diligence on behalf of investors.
– McGuireWoods’ global team of antitrust and competition lawyers excels at
finding creative, practical ways for life sciences clients to compete
aggressively while minimizing risks. Our lawyers assist clients with
designing marketing and distribution systems that comply with antitrust
laws, pricing and distribution issues, structuring joint ventures and
strategic alliances, and conducting antitrust audits and compliance
programs. They appear before courts and tribunals throughout the United
States and Europe, and represent clients in matters such as cartels,
parallel civil and criminal proceedings, and civil class actions and
Product Liability & Commercial Litigation
– Our decades of experience and ability to quickly understand the technical
and medical principles involved in each case enable us to mount an
effective defense against unwarranted claims and the tactics of plaintiffs’
counsel. We serve as lead defense counsel to life sciences companies in
class actions, multidistrict litigation and individual cases involving
devices, pharmaceuticals and biological products. Because of our
significant work in this space, McGuireWoods is nationally recognized in
product liability and mass tort litigation by Chambers USA and Legal 500.
McGuireWoods’ experience in these critical areas affecting life sciences
companies enables us to provide prompt, effective counsel in response to
changes in this dynamic market. In conjunction with our full-service public
McGuireWoods Consulting, we also provide strategic communications and government relations
guidance that helps life sciences businesses and industry coalitions shape
pending legislation and respond to state and federal initiatives.
In a series of video alerts, McGuireWoods’ healthcare lawyers address
issues providers face and overcoming COVID-19 challenges.